NGFR and malignant glioma: Here, we show for the first time to our knowledge that regulated intramembrane proteolysis of p75NTR is a requirement for the highly invasive behavior of p75NTR-positive malignant glioma, and designate RIP as a clinical target for the treatment of invasive malignant glioma.